Approval clinical trial in The Netherlands
AQLANE Medical™ received approval to start their multicenter clinical trial entitled “The use of a Polycaprolactone Based Bulking Agent for the Treatment of Female Stress Urinary Incontinence (SUI), a Pivotal Trial”, in The Netherlands.
Following the University Hospital in Antwerp (UZA), Belgium, two Dutch sites will start patient enrollment; the Catharina Hospital in Eindhoven and the Laurentius Hospital in Roermond.
The clinical trial is registered in the Dutch Trial Register (NTR) under number 6002, please click here to read the trial info.